NEW YORK –Laboratory Corporation of America said Wednesday that its Covance drug development unit will join the Tempus TIME Trial program to accelerate patient enrollment for oncology clinical trials.
To read the full story....
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.